Percutaneous myocardial laser revascularization and transmyocardial laser revascularization

The Agency for Healthcare Research and Quality (AHRQ), on behalf of the Centers for Medicare and Medicaid Services (CMS), has requested a technology assessment on transmyocardial laser revascularization (TMR) and percutaneous myocardial laser revascularization (PMR) in preparation for a Medicare Cov...

Full description

Bibliographic Details
Main Authors: Sarria-Santamera, Antonio, Liao, Lawrence (Author), Huntington, Ayn (Author), Matchar, David B. (Author)
Corporate Author: United States Agency for Healthcare Research and Quality
Format: eBook
Language:English
Published: Rockville, Maryland Agency for Healthcare Research and Quality 2004, June 22, 2004
Series:Technology assessment
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02315nam a2200289 u 4500
001 EB002002245
003 EBX01000000000000001165146
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
100 1 |a Sarria-Santamera, Antonio 
245 0 0 |a Percutaneous myocardial laser revascularization and transmyocardial laser revascularization  |h Elektronische Ressource  |c prepared for Agency for Healthcare Research and Quality, US Department of Health and Human Services ; prepared by the Duke Center for Clinical Health Policy Research and Evidence-based Practice Center ; Antonio Sarria-Santamera, Lawrence Liao, Ayn Huntington, David B. Matchar 
260 |a Rockville, Maryland  |b Agency for Healthcare Research and Quality  |c 2004, June 22, 2004 
300 |a 1 PDF file (132 pages) 
505 0 |a Includes bibliographical references 
700 1 |a Liao, Lawrence  |e [author] 
700 1 |a Huntington, Ayn  |e [author] 
700 1 |a Matchar, David B.  |e [author] 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Technology assessment 
500 |a Title from PDF title page 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK285179  |3 Volltext 
082 0 |a 700 
082 0 |a 610 
520 |a The Agency for Healthcare Research and Quality (AHRQ), on behalf of the Centers for Medicare and Medicaid Services (CMS), has requested a technology assessment on transmyocardial laser revascularization (TMR) and percutaneous myocardial laser revascularization (PMR) in preparation for a Medicare Coverage Advisory Committee meeting on this topic. The specific aims of this technology assessment are as follows: 1. Provide a summary and description of the technology.2. Review the peer-reviewed clinical literature on the outcomes associated with the use of: 1.1. TMR as a stand-alone procedure; 1.2. TMR used together with coronary artery bypass grafting (CABG);1.3. PMR.3. Review of available information on clinical trials underway as a horizon scan for this technology. In addition, studies on the mechanism of action and the specific lasers used for each of the procedures were reviewed, and a description of those findings is included in this report